Redefining response in wet AMD to anti VEGF therapy based on non-OCTA versus OCTA evaluation. Khatri A, Pandey A, Joshi K, Singh K, et al. Eur J Ophthalmol 2022;32:2719-2725.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Khatri A, Pandey A, Joshi K, Singh K, et al. Redefining response in wet AMD to anti VEGF therapy based on non-OCTA versus OCTA evaluation. Eur J Ophthalmol 2022;32:2719-2725.
PMID: 34796729